VOGLISUG-GM-1/1000 TABS
MRP: 960
Packaging: 10x10
Pack Type: tablet
Composition:
Voglibose 0.1mg + Glimepiride 1mg + Metformin HCL 1000
Indication:
Used for the treatment of type 2 diabetes mellitus when diet, exercise, or single-drug therapy are insufficient.
Description:
This triple-combination antidiabetic formulation brings together Voglibose 0.1 mg, Glimepiride 1 mg, and Metformin HCl 1000 mg to help support comprehensive management of type-2 diabetes under medical supervision.
Metformin assists in reducing hepatic glucose production and improving insulin sensitivity. Glimepiride enhances insulin secretion from pancreatic β-cells, aiding better glucose control. Voglibose helps delay glucose absorption by inhibiting intestinal enzymes, reducing post-meal sugar spikes.
Together, this combination targets multiple pathways of glucose regulation, helping maintain more stable blood sugar levels throughout the day when used as part of a medically supervised diabetes management plan.
Tags:
Usage Information
Dosage
Do NOT self-medicate. Follow the doctor’s prescribed dose only. Usually taken once or twice daily depending on physician advice Preferably taken with meals to reduce stomach discomfort Swallow whole with water Maintain consistent timing daily for best results
Side Effects
(Severity varies; seek medical guidance if symptoms persist) Stomach discomfort or bloating Diarrhea or nausea (Metformin-related) Low blood sugar (hypoglycemia) Dizziness or weakness Flatulence (Voglibose-related) Skin reactions (rare) Lactic acidosis (very rare; associated with Metformin)
Contraindications
Known allergy to Voglibose, Glimepiride, or Metformin Severe kidney impairment Severe liver disorders Diabetic ketoacidosis Hypoglycemic episodes Severe gastrointestinal conditions Not recommended for pregnancy or breastfeeding unless medically advised